LivaNova PLC Files 10-Q, Details Restructuring Plan
Ticker: LIVN · Form: 10-Q · Filed: 2024-08-01T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, restructuring, financials
TL;DR
LivaNova's Q2 10-Q shows restructuring costs, impacting financials. Keep an eye on severance expenses.
AI Summary
LivaNova PLC filed a 10-Q for the period ending June 30, 2024. The filing details financial performance and includes information on a restructuring plan, with specific figures related to employee severance and other costs associated with the plan. The company is based in London and operates in the electromedical and electrotherapeutic apparatus industry.
Why It Matters
This filing provides insight into LivaNova's financial health and strategic initiatives, including costs associated with its restructuring plan, which could impact future profitability and operations.
Risk Assessment
Risk Level: medium — The filing details a restructuring plan with associated costs, which introduces operational and financial risks that could affect the company's performance.
Key Numbers
- 20240630 — Reporting Period End Date (Indicates the financial period covered by the report.)
- 20240801 — Filing Date (The date the report was officially submitted to the SEC.)
Key Players & Entities
- LivaNova PLC (company) — Filer of the 10-Q report
- 20240630 (date) — End of the reporting period
- 20240801 (date) — Filing date of the report
- London (location) — Company's business address
- Sand Holdco Plc (company) — Former company name
- Sand Holdco Ltd (company) — Former company name
- A2024RestructuringPlanMember (other) — Identifier for restructuring plan costs
- EmployeeSeveranceMember (other) — Identifier for employee severance costs
FAQ
What is the total financial impact of the A2024RestructuringPlan as of June 30, 2024?
The filing indicates costs associated with the A2024RestructuringPlan, including employee severance, but specific total dollar amounts for the plan's impact are not detailed in the provided excerpt.
What were the specific dates of LivaNova's previous name changes?
The company was formerly known as Sand Holdco Plc, with a name change date of 20150420, and prior to that as Sand Holdco Ltd, with a name change date of 20150415.
What is LivaNova's primary industry classification?
LivaNova PLC is classified under ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS with the SIC code 3845.
What is the fiscal year end for LivaNova PLC?
LivaNova PLC's fiscal year ends on December 31 (1231).
Does the filing mention any specific subsequent events after the reporting period?
Note 14 is titled 'Subsequent Event', indicating that such events are discussed within the full filing, though details are not provided in the excerpt.
From the Filing
0001639691-24-000109.txt : 20240801 0001639691-24-000109.hdr.sgml : 20240801 20240801162345 ACCESSION NUMBER: 0001639691-24-000109 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 88 CONFORMED PERIOD OF REPORT: 20240630 FILED AS OF DATE: 20240801 DATE AS OF CHANGE: 20240801 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LivaNova PLC CENTRAL INDEX KEY: 0001639691 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 981268150 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-37599 FILM NUMBER: 241167100 BUSINESS ADDRESS: STREET 1: 20 EASTBOURNE TERRACE CITY: LONDON STATE: X0 ZIP: W2 6LG BUSINESS PHONE: 4402033250662 MAIL ADDRESS: STREET 1: 20 EASTBOURNE TERRACE CITY: LONDON STATE: X0 ZIP: W2 6LG FORMER COMPANY: FORMER CONFORMED NAME: Sand Holdco Plc DATE OF NAME CHANGE: 20150420 FORMER COMPANY: FORMER CONFORMED NAME: Sand Holdco Ltd DATE OF NAME CHANGE: 20150415 10-Q 1 livn-20240630.htm 10-Q livn-20240630 false 12/31 2024 Q2 0001639691 P5D P10D 0.016398 Note 14. Subsequent Event xbrli:shares iso4217:USD iso4217:USD xbrli:shares iso4217:GBP xbrli:shares xbrli:pure livn:repository_site iso4217:EUR livn:claim livn:segment livn:geographic_region 0001639691 2024-01-01 2024-06-30 0001639691 2024-07-26 0001639691 2024-04-01 2024-06-30 0001639691 2023-04-01 2023-06-30 0001639691 2023-01-01 2023-06-30 0001639691 2024-06-30 0001639691 2023-12-31 0001639691 2022-12-31 0001639691 2023-06-30 0001639691 2023-11-01 2024-06-30 0001639691 srt:MinimumMember livn:A2024RestructuringPlanMember 2024-06-30 0001639691 livn:A2024RestructuringPlanMember srt:MaximumMember 2024-06-30 0001639691 us-gaap:EmployeeSeveranceMember srt:MinimumMember livn:A2024RestructuringPlanMember 2024-06-30 0001639691 us-gaap:EmployeeSeveranceMember livn:A2024RestructuringPlanMember srt:MaximumMember 2024-06-30 0001639691 srt:MinimumMember livn:A2024RestructuringPlanMember us-gaap:ContractTerminationMember 2024-06-30 0001639691 livn:A2024RestructuringPlanMember srt:MaximumMember us-gaap:ContractTerminationMember 2024-06-30 0001639691 livn:A2024RestructuringPlanMember 2024-04-01 2024-06-30 0001639691 livn:A2024RestructuringPlanMember 2024-01-01 2024-06-30 0001639691 us-gaap:EmployeeSeveranceMember 2023-12-31 0001639691 us-gaap:ContractTerminationMember 2023-12-31 0001639691 us-gaap:EmployeeSeveranceMember 2024-01-01 2024-06-30 0001639691 us-gaap:ContractTerminationMember 2024-01-01 2024-06-30 0001639691 us-gaap:EmployeeSeveranceMember 2024-06-30 0001639691 us-gaap:ContractTerminationMember 2024-06-30 0001639691 livn:NeuromodulationSegmentMember us-gaap:OperatingSegmentsMember 2024-04-01 2024-06-30 0001639691 livn:NeuromodulationSegmentMember us-gaap:OperatingSegmentsMember 2023-04-01 2023-06-30 0001639691 livn:NeuromodulationSegmentMember us-gaap:OperatingSegmentsMember 2024-01-01 2024-06-30 0001639691 livn:NeuromodulationSegmentMember us-gaap:OperatingSegmentsMember 2023-01-01 2023-06-30 0001639691 us-gaap:CorporateNonSegmentMember 2024-04-01 2024-06-30 0001639691 us-gaap:CorporateNonSegmentMember 2023-04-01 2023-06-30 0001639691 us-gaap:CorporateNonSegmentMember 2024-01-01 2024-06-30 0001639691 us-gaap:CorporateNonSegmentMember 2023-01-01 2023-06-30 0001639691 us-gaap:NondesignatedMember us-gaap:FairValueMeasurementsRecurringMember livn:FreestandingInstrumentMember 2024-06-30 0001639691 us-gaap:NondesignatedMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member livn:FreestandingInstrumentMember 2024-06-30 0001639691 us-gaap:NondesignatedMember us-gaap:FairValueMeasurementsRecurringMember livn:FreestandingInstrumentMember us-gaap:FairValueInputsLevel2Member 2024-06-30 0001639691 us-gaap:NondesignatedMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember livn:FreestandingInstrumentMember 2024-06-30 0001639691 us-gaap:NondesignatedMembe